Latest Period
Q1 2026
Security Snapshot
Evaxion Biotech A/S - American Depositary Shares, each representing fifty Ordinary Shares, DKK 0.25 nominal value per share (EVAX) Institutional Ownership
CUSIP: 29970R204
13F Institutional Holders and Ownership History from Q4 2023 to Q1 2026
Institutions Reporting
1
Shares (Excl. Options)
1,214,126
Price
$3.72
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / American Depositary Shares, each representing fifty Ordinary Shares, DKK 0.25 nominal value per share
- Symbol
- EVAX on Nasdaq
- All holders as of 31 Mar 2026
- Q1 2026
- Total 13F shares
- 1,214,126
- Total 13F value
- $4,516,549
- Share change
- 0
- Number of holders
- 1
- Shares outstanding
- 315,652,014
- SEC-reported price per share
- $3.72
Latest holder snapshot
3 signals
Issuer context
Names, identifiers, and filing context for this profile.
2 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- EVAX - Evaxion Biotech A/S - American Depositary Shares, each representing fifty Ordinary Shares, DKK 0.25 nominal value per share is tracked under CUSIP 29970R204.
- 1 institution reported positions in Q1 2026.
- 1 significant owner is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 1 to 1 between Q4 2025 and Q1 2026.
- SEC-reported value moved from $5,791,381 to $4,516,549.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 1 institution filings for Q1 2026.
Security key
29970R204
Latest holder period
Q1 2026
13F holders
1
13D/G owners
1
CIK / CUSIP context first
Open Q1 2026 holders
EVAX full holder history
Evaxion A/S SEC filings
Evaxion A/S company facts
Evaxion A/S insider transactions
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 29970R204:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
1
Security
EVAX
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| Merck & Co., Inc. | 20% | $105,531,938 | 63,004,142 | Merck & Co., Inc. | 31 Jan 2025 |
As of 31 Mar 2026, 1 institutional investors reported holding 1,214,126 shares of Evaxion Biotech A/S - American Depositary Shares, each representing fifty Ordinary Shares, DKK 0.25 nominal value per share (EVAX). This represents 0.38% of the company’s total 315,652,014 outstanding shares.
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
10
Latest
Q1 2026
Rows shown
1-10 of 10
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q1 | 1,214,126 | $4,516,549 | $3.72 | 1 | |
| 2025 Q4 | 1,214,126 | $5,791,381 | -$7 | $4.77 | 1 |
| 2025 Q3 | 1,214,128 | $4,565,121 | $3.63 | 2 | |
| 2025 Q2 | 1,214,128 | $2,974,613 | $2.22 | 2 | |
| 2025 Q1 | 1,214,128 | $2,246,136 | +$1,019,666 | $1.68 | 2 |
| 2024 Q4 | 806,483 | $681,502 | -$277,604 | $0.85 | 9 |
| 2024 Q3 | 548,474 | $1,705,753 | +$291,174 | $3.11 | 8 |
| 2024 Q2 | 453,337 | $1,313,498 | +$206,104 | $2.89 | 6 |
| 2024 Q1 | 381,029 | $1,219,293 | +$1,212,436 | $3.20 | 6 |
| 2023 Q4 | 10,000 | $6,857 | +$6,857 | $0.69 | 1 |